Receptor activator of NF-κB ligand arrests bone growth and promotes cortical bone resorption in growing rats

scientific article published on April 11, 2003

Receptor activator of NF-κB ligand arrests bone growth and promotes cortical bone resorption in growing rats is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1152/JAPPLPHYSIOL.00056.2003
P953full work available at URLhttp://intl-jap.physiology.org/cgi/content/abstract/95/2/672
https://www.physiology.org/doi/pdf/10.1152/japplphysiol.00056.2003
P698PubMed publication ID12692138
P5875ResearchGate publication ID10807874

P2093author name stringHaydee M. Vercesi
John A. Hey
Nansie A. McHugh
Robert W. Egan
P2860cites workBirth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis 1Q22306225
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activationQ24311588
RANK is essential for osteoclast and lymph node developmentQ24598872
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcificationQ24603266
Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand familiesQ28137631
Regulation of the differentiation and function of osteoclastsQ34010151
Changes in bone mineral density with age in men and women: a longitudinal studyQ34119625
Perimenopausal risk of falling and incidence of distal forearm fractureQ35712526
TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.Q36404187
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolismQ37108966
Basic biomechanical measurements of bone: a tutorialQ40797364
Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiencyQ40868586
Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat.Q41352329
In vivo rat assay: bone remodeling and steroid effects on juvenile bone by pQCT quantification in 7 daysQ44185357
Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 miceQ46092958
Age-related changes in the tensile properties of cortical bone. The relative importance of changes in porosity, mineralization, and microstructureQ46296154
Deficient acquisition of bone during maturation underlies idiopathic osteoporosis in men: evidence from a three-generation family studyQ49034316
Intracapsular hip fracture and the region-specific loss of cortical bone: analysis by peripheral quantitative computed tomography.Q52059123
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-βQ57675150
Peak bone massQ72176094
Catabolic effects of continuous human PTH (1--38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formationQ74411385
A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitroQ77342999
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectphysiologyQ521
P304page(s)672-676
P577publication date2003-04-11
P1433published inJournal of Applied PhysiologyQ1091719
P1476titleReceptor activator of NF-κB ligand arrests bone growth and promotes cortical bone resorption in growing rats
P478volume95